Modulation of RAB7A Protein Expression Determines Resistance to Cisplatin through Late Endocytic Pathway Impairment and Extracellular Vesicular Secretion

Background: Cisplatin (CDDP) is widely used in treatment of cancer, yet patients often develop resistance with consequent therapeutical failure. In CDDP-resistant cells alterations of endocytosis and lysosomal functionality have been revealed, although their causes and contribution to therapy respon...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Guerra, Flora, Paiano, Aurora, Migoni, Danilo, Girolimetti, Giulia, Perrone, Anna Myriam, De Iaco, Pierandrea, Fanizzi, Francesco Paolo, Gasparre, Giuseppe, Bucci, Cecilia
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357196/
https://ncbi.nlm.nih.gov/pubmed/30626032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11010052
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki